Prehospital Fibrinolysis Followed By Urgent Percutaneous Coronary Intervention After ST-elevation Myocardial Infarction

References

• Reimer KA , LoweJE, RasmussenMM, JenningsRB . The wave front phenomenon of ischemic cell death: myocardial infarct size vs. duration of coronary occlusion in dogs . Circulation56, 786 – 794 ( 1977 ).
   PubMed Web of Science ®Google Scholar
• Eitel I , DeschS, FuernauGet al. Prognostic significance and determinants of myocardial salvage assessed by cardiovascular magnetic resonance in acute reperfused myocardial infarction . J. Am. Coll. Cardiol.55 ( 22 ), 2470 – 2479 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• The European Myocardial Infarction Project Group . Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction . N. Engl. J. Med.329, 383 – 389 ( 1993 ).
   PubMed Web of Science ®Google Scholar
• Dudek D , RakowskiT, DziewierzA, MieleckiW . Time delay in primary angioplasty: how relevant is it?Heart93 ( 10 ), 1164 – 1166 ( 2007 ).
   PubMed Web of Science ®Google Scholar
• Levine GN , BatesER, BlankenshipJCet al. 2015 ACC/AHA/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF/AHA/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF/AHA guideline for the management of st-elevation myocardial infarction . J. Am. Coll. Cardiol.67 ( 10 ), 1235 – 1250 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Jneid H , AddisonD, BhattDLet al. 2017 AHA/ACC clinical performance and quality measures for adults with ST-elevation and non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures . J. Am. Coll. Cardiol.70 ( 16 ), 2048 – 2090 ( 2017 ).
   PubMedGoogle Scholar
• Assessment of the Safety and Efficacy of a New Treatment Strategy with Percutaneous Coronary Intervention (ASSENT-4 PCI) investigators . Primary versus tenecteplase-facilitated percutaneous coronary intervention in patients with ST-segment elevation acute myocardial infarction (ASSENT-4 PCI): randomized trial . Lancet367 ( 9510 ), 569 – 578 ( 2006 ).
   PubMed Web of Science ®Google Scholar
• Denktas AE , AtharH, HenryTDet al. Reduced-dose fibrinolytic acceleration of ST-segment elevation myocardial infarction treatment coupled with urgent percutaneous coronary intervention compared with primary percutaneous coronary intervention alone results of the AMICO (Alliance for Myocardial Infarction Care Optimization) registry . JACC Cardiovasc. Interv.1 ( 5 ), 504 – 510 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Cantor WJ , FitchettD, BorgundvaagBet al. TRANSFER-AMI Trial Investigators . Routine early angioplasty after fibrinolysis for acute myocardial infarction . N. Engl. J. Med.360 ( 26 ), 2705 – 2718 ( 2009 ).
   PubMed Web of Science ®Google Scholar
• B⊘hmer E , HoffmannP, AbdelnoorM, ArnesenH, HalvorsenS . Efficacy and safety of immediate angioplasty versus ischemia-guided management after thrombolysis in acute myocardial infarction in areas with very long transfer distances results of the NORDISTEMI (NORwegian study on DIstrict treatment of ST-elevation myocardial infarction) . J. Am. Coll. Cardiol.55 ( 2 ), 102 – 110 ( 2010 ).
   PubMed Web of Science ®Google Scholar
• Di Mario C , DudekD, PiscioneFet al. CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators . Immediate angioplasty versus standard therapy with rescue angioplasty after thrombolysis in the Combined Abciximab REteplase Stent Study in Acute Myocardial Infarction (CARESS-in-AMI): an open, prospective, randomized, multicenter trial . Lancet371 ( 9612 ), 559 – 568 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Ellis SG , TenderaM, de BelderMAet al. FINESSE Investigators . Facilitated PCI in patients with ST-elevation myocardial infarction . N. Engl. J. Med.358 ( 21 ), 2205 – 2217 ( 2008 ).
   PubMed Web of Science ®Google Scholar
• Rashid MK , GuronN, BernickJet al. Safety and efficacy of a pharmacoinvasive strategy in st-segment elevation myocardial infarction: a patient population study comparing a pharmacoinvasive strategy with a primary percutaneous coronary intervention strategy within a regional system . JACC Cardiovasc. Interv.9 ( 19 ), 2014 – 2020 ( 2016 ).
   PubMed Web of Science ®Google Scholar
• Bhatt NS , SolhpourA, BalanPet al. Comparison of in-hospital outcomes with low-dose fibrinolytic therapy followed by urgent percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction . Am. J. Cardiol.111 ( 11 ), 1576 – 1579 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Solhpour A , ChangKW, BalanPet al. Comparison of outcomes for patients ≥75 years of age treated with prehospital reduced-dose fibrinolysis followed by percutaneous coronary intervention versus percutaneous coronary intervention alone for treatment of ST-elevation myocardial infarction . Am. J. Cardiol.113 ( 1 ), 60 – 63 ( 2014 ).
   PubMed Web of Science ®Google Scholar
• Armstrong PW , GershlickAH, GoldsteinPet al. STREAM Investigative Team . Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction . N. Engl. J. Med.368 ( 15 ), 1379 – 1387 ( 2013 ).
   PubMed Web of Science ®Google Scholar
• Borgia F , GoodmanSG, HalvorsenSet al. Early routine percutaneous coronary intervention after fibrinolysis vs. standard therapy in ST-segment elevation myocardial infarction: a meta-analysis . Eur. Heart J.31 ( 17 ), 2156 – 2169 ( 2010 ).
   PubMed Web of Science ®Google Scholar